SNRIs are another type of antidepressant medication that increase levels of norepinephrine and serotonin in the brain by inhibiting their reabsorption into neurons.
Reuptake inhibitors are primarily discussed within the biological perspective of psychology, which considers the physiological bases of behavior in humans and animals. This perspective views mental processes as products of neurochemical interactions.
Research on reuptake inhibitors has often focused on their therapeutic effects in treating psychiatric disorders. Key studies have demonstrated their efficacy in managing depression, anxiety, and other mood disorders by altering neurotransmitter levels in the brain.